Molecular breast imaging: Advantages and limitations of a scintimammographic technique in patients with small breast tumors

Breast Journal

Volumn 13, Issue 1, 2007, Pages 3-11

  O'Connor, Michael K ^a   Phillips, Stephen W ^a   Hruska, Carrie B ^a   Rhodes, Deborah J ^a   Collins, Douglas A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Molecular breast imaging; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; BREAST SURGERY; BREAST TUMOR; COMPRESSION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MOLECULAR IMAGING; OCCULT CANCER; PAIN; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; THICKNESS; TUMOR BIOPSY; TUMOR DIAGNOSIS; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 33845970542     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2006.00356.x     Document Type: Article

References (37)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
3. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004;96:1432-40.
4. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225:165-75.
5. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
6. Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. Am J Roentgenol 2003;180:1225-28.
7. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215:267-79.
8. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002;21:115-24.
9. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-25.
10. Kriege M, Brekelmans CT, Boetes C, et al. Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351: 427-37.
11. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-36.
12. Taillefer R. The role of 99mTc sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 1999;29:16-40.
13. Waxman AD. The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 1997;27:40-54.
14. Mekhmandarov S, Sandbank J, Cohen M, et al. Technetium-99m- sestamibi prone scintimammography in palpable and nonpalpable breast tumors. J Nucl Med 1998;39:86-90.
15. Tofani A, Sciuto R, Semprebene A, et al. 99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy. Nucl Med Commun 1999;20:1113-21.
16. Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47:134-49.
17. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63:181-87.
18. Scopinaro F, Pani R, De Vincentis G, Soluri A, Pellegrini R, Porfini LM. High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera. Eur J Nucl Med 1999;26:1279-88.
19. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High resolution scintimammography: a pilot study. J Nucl Med 2002;43:909-15.
20. Coover LR, Caravaglia G, Kuhn P. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J Nucl Med 2004;45:553-58.
21. Mueller B, O'Connor MK, Blevis I, et al. Evaluation of a small CZT detector for scintimammography. J Nucl Med 2003;44:602-9.
22. Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using Tc-99m scintimammography for the detection of small breast lesions. Mayo Clinic Proc 2005;80:24-30.
23. American College of Radiology. Illustrated Breast Imaging Reporting and Data System (BI-RADS), 4th edn. Reston, VA: American College of Radiology, 2003.
24. Hruska CB, O'Connor MK, Collins DA. Comparison of small field of view gamma camera systems for scintimammography. Nucl Med Commun 2005;26:441-45.
25. Kremer E, Atkinson J, Ingelzi R. Measurement of pain patient preference does not confound pain measurement. Pain 1981;10:241-48.
26. Palmedo H, Biersack HJ, Lastoria S, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 1997;25:375-85.
27. Dibble SL, Israel J, Nussey B, Sayre JW, Brenner RJ, Sickles EA. Mammography with breast cushions. Women's Health Issues 2005;15:55-63.
28. Khalkhali I, Villanueva-Meyer J, Edell JL, et al. Diagnostic accuracy of 99mTc sestamibi breast imaging: multicenter trial results. J Nucl Med 2000;41:1973-79.
29. Spanu A, Schillaci O, Meloni GB, et al. The usefulness of 99mTc tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas. Int J Oncol 2002;21:831-40.
30. Pani R, Scopinaro F, De Paola G, et al. Very high-resolution gamma camera based on position sensitive photo-multiplier tube. Phys Medica 1993;IX:233-36.
31. Pani R, Pellegrini R, Scopinaro F, et al. Scintillating array gamma camera for clinical use. Nucl Instrum Methods 1997;A392:295-98.
32. Pani R, De Vincentis G, Scopinaro F, et al. Dedicated gamma camera for single photon emission mammography (SPEM). IEEE Trans Nucl Sci 1998;45:3127-30.
33. MIRALUMA. Kit for the Preparation of Technetium Tc99m Sestamibi for Injection. North Billerica, MA: Bristol-Myers Squibb Medical Imaging 513158-1201, December 2001.
34. Abe A, Takahashi N, Lee J, et al. Performance evaluation of a hand-held, semiconductor (CdZnTe)-based gamma camera. Eur J Nucl Med Mol Imaging 2003;30:805-11.
35. Tsuchimochi M, Sakahara H, Hayama K, et al. A prototype small CdTe gamma camera for radioguided surgery and other imaging applications. Eur J Nucl Med Mol Imaging 2003;30:1605-14.
36. Blane CE, Fitzgerald JT, Gruppen LD, Oh MS, Helvie MA, Andersson I. Decreasing rate of fatty involution at screening mammography. Acad Radiol 2002;9:895-98.
37. Verbeek ALM. The influence of breast density on the sensitivity of mammography screening. Eur J Cancer 2004;40(Suppl. 2):57.